Hsinchu, Taiwan

Chung-Ming Sun

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Rancho Cucamonga, CA (US) (2010 - 2013)
  • Hsinchu, TW (2013 - 2022)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Innovations of Chung-Ming Sun: A Pioneer in Neurological Research

Introduction

Chung-Ming Sun is a distinguished inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of neurological research, holding a total of 12 patents. His work primarily focuses on developing novel compounds that can aid in the treatment and prevention of neurological disorders.

Latest Patents

Among his latest patents are the "Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors." This invention provides innovative substituted benzimidazole derivatives that serve as DAAO inhibitors, which are crucial for the treatment and prevention of various neurological disorders. The significance of these compounds lies in their potential to improve therapeutic outcomes for patients suffering from such conditions.

Career Highlights

Chung-Ming Sun has had a notable career, working at prestigious institutions such as National Taiwan University and National Yang Ming Chiao Tung University. His research has not only advanced scientific understanding but has also paved the way for new therapeutic strategies in neurology.

Collaborations

Throughout his career, Chung-Ming Sun has collaborated with esteemed colleagues, including Yufeng Jane Tseng and Yu-Li Liu. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Chung-Ming Sun's innovative work in the field of neurological research exemplifies the importance of scientific inquiry and collaboration. His contributions through patents and research continue to influence the landscape of treatment options for neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…